Tech Company Financing Transactions
Vantis Vascular Funding Round
National Institutes of Health and private investors joined a $10 million Series B venture round for Vantis Vascular. The round closed on 12/17/2024.
Transaction Overview
Company Name
Announced On
12/17/2024
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series B
Investors
Proceeds Purpose
Vantis intends to use the funds to initiate US commercialization of its CrossFAST� Integrated Microcatheter Advanced Delivery System.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
2570 N First St. 200
San Jose, CA 95131
USA
San Jose, CA 95131
USA
Phone
Undisclosed
Website
Email Address
Overview
Founded by physicians to develop performance-driven technology for vascular interventions. We design solutions to provide faster, easier, and safer procedures, specifically targeting navigation challenges in complex, calcified, and tortuous anatomies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jason Turner
Chief Medical Officer
Tim Fischell
Chief Technical Officer
Mike Mirizzi
VP - Bus. Development
Gary McCord
VP - Operations
James Abrams
VP - Regulatory Affairs
Angela Thompson
Browse more venture capital transactions:
Prev: 12/17/2024: FastWave Medical venture capital transaction
Next: 12/17/2024: Hostaway venture capital transaction
Share this article
Where The Data Comes From
We record tech company VC transactions. VC investment data records reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs